Sector portfolio · VC firm · United States

F-Prime Capital's Biotech portfolio

F-Prime Capital has backed 48 Biotech startups in rounds we track, $6.7B between them, shown by the stage each has reached. The best-funded is Blueprint Medicines.

48startups backed
5stages
$6.7Braised between them
Series C and laterbiggest stage

F-Prime Capital's whole portfolioF-Prime Capital's profile

Series C and later

16

Series B

15

Series A

9

Stage not reported

6

Pre-seed and seed

2

Segment by segment

Series C and later

16 startups · $3.6B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. IMInsilico MedicineHong Kong SAR China$392M
  3. Innovent BiologicsEstablished in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for China$385M
  4. Coherus BiosciencesCoherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.United States$299M
  5. OOvivaSwitzerland$246M
  6. TraceLinkTraceLink is a leading digital network platform that specializes in the orchestration of the pharmaceutical and life sciences supply chain.United States$174M
  7. Mersana TherapeuticsMersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.United States$148M
  8. PulmocidePulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007.United Kingdom$110M

Series B

15 startups · $2.2B raised

  1. Denali TherapeuticsDenali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.United States$547M
  2. Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.United States$322M
  3. T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
  4. Hua MedicineHua Medicine is a clinical-stage, innovative drug development company in China.China$192M
  5. Semma TherapeuticsSemma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.United States$158M
  6. US HealthVestUS HealthVest is a behavioral healthcare firm that helps the development of psychiatric hospitals.United States$141M
  7. SonoTheraSonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies.United States$125M
  8. Nocion TherapeuticsNocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.United States$112M

Series A

9 startups · $464M raised

  1. Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
  2. RTR1 TherapeuticsUnited States$78M
  3. GPGenoa PharmaceuticalsGenoa Pharmaceuticals developes improved therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF).United States$63M
  4. ATAkrevia TherapeuticsUnited States$30M
  5. Modis TherapeuticsModis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.United States$30M
  6. Countable LabsCountable Labs is a biotechnology company based in Palo Alto, California, focused on next-generation genomics and precision DNA quUnited States$26M
  7. Embark VeterinaryEmbark Veterinary is a Boston-based company specializing in canine genomics and biotechnology, founded in 2015.United States$15M
  8. NHNotabel HealthUnited States$14M

Stage not reported

6 startups · $411M raised

  1. Leyden LabsLeyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions foNetherlands$221M
  2. PPrecisionUnited States$111M
  3. CPCaplin PointIndia$31M
  4. OOrchardUnited States$30M
  5. NovaerusNovaerus Improve the business and quality of care through the application of airborne pathogen control technology.United States$10M
  6. LunaPBCLunaPBC is a healthcare company that transforms health data into health breakthroughs.United States$8.4M

Pre-seed and seed

2 startups · $7.5M raised

  1. Nebula GenomicsNebula Genomics is a personal genomics company based in San Francisco, California, founded in 2016 by Dr.United States$4.3M
  2. TempestTempest is a Celtic rock band based in the San Francisco Bay Area, active since 1988.United States$3.2M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names F-Prime Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioF-Prime Capital's Healthtech portfolio11 startups · $1.1BSector portfolioF-Prime Capital's Fintech portfolio11 startups · $853MCo-investorsWho invests with F-Prime Capital107 co-investorsPortfolio mapF-Prime Capital portfolio map87 startups · $11BSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36B

Raising from investors like F-Prime Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps